Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Financing Activities (2023 - 2025)

Mangoceuticals' Cash from Financing Activities history spans 3 years, with the latest figure at $2.1 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 85.61% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 76.12% increase, with the full-year FY2025 number at $7.3 million, up 76.12% from a year prior.
  • Cash from Financing Activities hit $2.1 million in Q4 2025 for Mangoceuticals, up from $1.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MGRX hit a ceiling of $5.0 million in Q1 2023 and a floor of $267500.0 in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $1.7 million across 3 years, with a median of $1.3 million in 2025.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 94.65% in 2024 and later skyrocketed 754.21% in 2025.
  • Tracing MGRX's Cash from Financing Activities over 3 years: stood at $1.2 million in 2023, then dropped by 6.46% to $1.1 million in 2024, then soared by 85.61% to $2.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for MGRX at $2.1 million in Q4 2025, $1.6 million in Q3 2025, and $1.3 million in Q2 2025.